Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Generative AI for Sleep Promotion

20. juli 2026 opdateret af: New York University
Sleep is a major public health concern in the United States. Major guidelines recommend that adults obtain at least 7 hours of sleep per night. More than 25% of U.S. adults do not meet this recommendation, and 14.5% report difficulty falling asleep on most days or every day during the past month. The investigators developed a low-cost, easily accessible sleep intervention using artificial intelligence (AI) technologies. The purpose of this study is to examine the effect of this intervention on sleep outcomes among U.S. adults.

Studieoversigt

Status

Rekruttering

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

After providing informed consent, participants will complete a baseline assessment and then be randomized to either the AI chatbot intervention or a waitlist control. The intervention group will receive immediate access to the AI-powered sleep chatbot for 2 weeks, while the waitlist control group will continue their usual sleep habits without chatbot access. Following the post-intervention assessment, participants in the waitlist control group will receive access to the chatbot. Follow-up assessments will be conducted at 3 and 6 months after randomization.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

60

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

    • New York
      • New York, New York, Forenede Stater, 10010
        • Rekruttering
        • New York University
      • New York, New York, Forenede Stater, 10010
        • Afsluttet
        • New York University

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Aged 18-75 years
  • had a raw score of 23 or higher on the Patient-Reported Outcomes Measurement Information System (PROMIS™) Sleep Disturbance
  • had a smartphone and be able to access the internet
  • willing and able to participate through text messages on a smartphone
  • able to read and understand English

Exclusion Criteria:

  • pregnant or lactating
  • concurrently participating in other research studies focused on lifestyle modifications

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Intervention
Participants will receive access to an AI-based chatbot and engage with it via text messaging for 2 weeks.
Participants engage with an AI chatbot for two weeks to learn personalized education and skills regarding sleep promotion
Aktiv komparator: Waitlist control
Participants will continue their usual sleep habits for 2 weeks without access to the AI-based chatbot. After the 2-week waitlist period, participants will receive access to the chatbot and engage with it via text messaging for 2 weeks.
Participants engage with an AI chatbot for two weeks to learn personalized education and skills regarding sleep promotion

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Fitbit-measured sleep duration
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Sleep duration will be measured objectively using Fitbit and defined as the total amount of time spent asleep during the primary sleep period, expressed in minutes.
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Fitbit-measured sleep onset
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Sleep onset will be measured objectively using Fitbit and defined as the time from attempting to fall asleep to sleep onset, expressed in minutes.
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Fitbit-measured sleep efficiency
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Sleep efficiency will be measured objectively using Fitbit and defined as the percentage of time spent asleep while in bed, expressed as a percentage (%).
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Fitbit-measured wake after sleep onset
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Wake after sleep onset will be measured objectively using Fitbit and defined as the total amount of time participants are awake after initially falling asleep until the final awakening, expressed in minutes.
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Perceived sleep quality
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Perceived sleep quality measured by the Pittsburgh Sleep Quality Index. The total score ranges from 0 to 21, with higher scores indicating worse sleep quality.
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Daytime sleepiness
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Daytime sleepiness will be measured using the Epworth Sleepiness Scale. The total score ranges from 0 to 24, with higher scores indicating greater daytime sleepiness.
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Sleep hygiene
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Sleep hygiene will be measured using the Sleep Hygiene Index. The total score ranges from 13 to 65, with a higher score indicating poorer sleep hygiene (a worse outcome).
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Sleep environment
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Sleep Environment measured by the Assessment of Sleep Environment
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Number of awakenings
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Number of awakenings will be measured objectively using Fitbit and defined as the total number of wake episodes occurring during the primary sleep period, expressed as the number of awakenings.
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Light sleep duration
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Light sleep duration will be measured objectively using Fitbit and defined as the total time spent in the light sleep stage during the primary sleep period, expressed in minutes.
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Deep sleep duration
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Deep sleep duration will be measured objectively using Fitbit and defined as the total time spent in the deep sleep stage during the primary sleep period, expressed in minutes.
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Rapid eye movement sleep duration
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Rapid eye movement sleep duration will be measured objectively using Fitbit and defined as the total time spent in the rapid eye movement sleep stage during the primary sleep period, expressed in minutes.
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Wake duration
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Wake duration will be measured objectively using Fitbit and defined as the total time spent awake during the primary sleep period, expressed in minutes.
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Dysfunctional beliefs and attitudes about sleep
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Dysfunctional beliefs and attitudes about sleep will be measured using the Dysfunctional Beliefs and Attitudes about Sleep Scale (DBAS-16). The total scores range from 0 to 10, with a higher score indicating more dysfunctional beliefs and attitudes about sleep.
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Perceived stress
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Perceived stress will be measured using the Perceived Stress Scale-4. The total score ranges from 0 to 16, with a higher score indicating greater perceived stress.
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Anxiety
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Anxiety will be measured using the Generalized Anxiety Disorder-2. The total score ranges from 0 to 6, with a higher score indicating greater anxiety symptom severity.
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Fatigue
Tidsramme: Baseline, 2-week post-intervention, and 3- and 6-month follow-ups
Fatigue will be measured using the Fatigue Severity Scale. The total score ranges from 1 to 7, with a higher score indicating greater fatigue severity.
Baseline, 2-week post-intervention, and 3- and 6-month follow-ups

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. oktober 2025

Primær færdiggørelse (Anslået)

1. juli 2027

Studieafslutning (Anslået)

31. december 2027

Datoer for studieregistrering

Først indsendt

21. januar 2026

Først indsendt, der opfyldte QC-kriterier

20. juli 2026

Først opslået (Faktiske)

22. juli 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

22. juli 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

20. juli 2026

Sidst verificeret

1. juli 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • FY2024-9037

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

To protect participants' personal information and privacy

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Søvnproblemer

Kliniske forsøg med AI-based chatbot

Abonner